Skip to content
10-Q/A

Quarterly Report

BioPower Operations Corporation

0001493152-23-029785

← back to feed
Filed
Aug 22, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated Q1 2023 · Jun 16, 2023 45.87M sh
Operating Cash Flow Q1 2023 · Feb 28, 2023 −$690
Operating Cash Flow Q1 2023 · Feb 28, 2022 −$87.49K
Cash And Equivalents Q1 2023 · Feb 28, 2023 $135
Cash And Equivalents Q1 2023 · Nov 30, 2022 $825
Stockholders Equity restated Q1 2023 · Feb 28, 2023 −$6.54M
Stockholders Equity Q1 2023 · Nov 30, 2022 −$5.94M
Stockholders Equity Q1 2023 · Feb 28, 2022 −$5.41M
Stockholders Equity Q1 2023 · Nov 30, 2021 −$5.41M
Current Liabilities restated Q1 2023 · Feb 28, 2023 $6.56M
Current Liabilities Q1 2023 · Nov 30, 2022 $5.95M
Total Assets Q1 2023 · Feb 28, 2023 $13.36K
Total Assets Q1 2023 · Nov 30, 2022 $14.05K
Eps Basic restated Q1 2023 · Feb 28, 2023 −$0.01
Eps Basic Q1 2023 · Feb 28, 2022 $0.00
Sga Expense Q1 2023 · Feb 28, 2023 $50.85K
Sga Expense Q1 2023 · Feb 28, 2022 $151.43K
Rd Expense Q1 2023 · Feb 28, 2023 $432.37K
Net Income restated Q1 2023 · Feb 28, 2023 −$629.61K
Net Income Q1 2023 · Feb 28, 2022 $1.18K
Operating Income restated Q1 2023 · Feb 28, 2023 −$483.22K
Operating Income Q1 2023 · Feb 28, 2022 $48.58K
Revenue Q1 2023 · Feb 28, 2022 $200K